14 participants
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-10-10
- Start Date:
- 2003-09-03
- Completion:
- 2005-09-05
Conditions
- Cancer
- Neoplasm
Interventions
- BIOLOGICAL